Lv1
48 积分 2022-11-24 加入
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
15小时前
待确认
Interleukin-18 armours antitumour immune effectors
4天前
已完结
In vivo engineering tumor cells to a universal “all-in-one” cancer vaccine with full antigen spectrum
19天前
已完结
Functional Fv fragment of an antibody specific for CD28: Fv‐mediated co‐stimulation of T cells
1个月前
已完结
Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state
1个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
2个月前
已完结
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
2个月前
已完结
Regional delivery of hypoxia-responsive CAR T cells improves efficacy for solid tumors
2个月前
已完结
CBLB Deficiency in Human CD4+ T Cells Results in Resistance to T Regulatory Suppression through Multiple Mechanisms
3个月前
已完结
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunity
3个月前
已完结
皖公网安备34019202002308
